Unexpectedly, while T cells activated in TCM from infected tumours could upregulate c-Myc to a certain extent, this was substantially dampened compared to the NT control (p < 0.05 NT vs STm in CD4s and CD8s) at late-stage activation (Fig. 6F), coinciding with the observation of impaired expression of glycolytic enzymes at the same timepoint. This evidence concerns the gene MYC and neoplasm.